Calcium overload toxicity and functional impairment in peritoneal leukocytes elicited by glycogen or interleukin-1β
- 1 March 1994
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 41 (1-2) , 101-104
- https://doi.org/10.1007/bf01986406
Abstract
Although calcium plays an important role in the activation of leukocytes for such processes as eicosanoid biosynthesis, secretion of granular constituents and superoxide generation, sustained high levels of intracellular calcium ions may be toxic. We have previously found that high concentrations of calcium ionophores induce a rapid-onset “calcium overload” toxicity in rat peritoneal leukocytes, in which functional responses such as β-glucuronidase secretion, superoxide generation and leukotriene B4 synthesis are greatly attenuated, and some leakage of cytoplasmic LDH occurs. We have now compared this phenomenon in peritoneal leukocytes elicited from animals pretreated in three ways: glycogen, interleukin-1β (IL-1β) alone or glycogen plus IL-1β. Peritoneal administration of IL-1β caused elicitation of cells which were enriched in eosinophils; however, the functional responses of the cells in all three groups were broadly similar in terms of the ability of the agonists FMLP, PMA and A23187 to initiate superoxide generation, β-glucuronidase secretion and leukotriene generation. Cells from all three treatment groups showed diminished responsiveness at 10−5 M A23187, indicative of calcium overload toxicity. This was most evident for the superoxide and β-glucuronidase responses. Some quantitative differences observed between treatment groups may reflect the different sensitivities of the various cells contained in the mixed leukocyte preparations. We conclude that IL-1β induces leukocyte emigration into the peritoneal cavity but that the cell population is different from that induced by glycogen. However, the cells retain susceptibility to calcium overload toxicity.Keywords
This publication has 10 references indexed in Scilit:
- Determination of the primary and secondary structure of NAP-1/IL-8 and a monocyte chemoattractant protein, MCP-1/MCAF.1990
- Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone.The Journal of Immunology, 1989
- NEUTROPHIL STIMULATION BY RECOMBINANT CYTOKINES AND A FACTOR PRODUCED BY IL-1-TREATED HUMAN SYNOVIAL CELL-CULTURES1988
- Selectivity of Neutrophil 5-Lipoxygenase and Cyclo-oxygenase Inhibition by an Anti-inflammatory Flavonoid Glycoside and Related Aglycone FlavonoidsJournal of Pharmacy and Pharmacology, 1988
- A novel neutrophil-activating factor produced by human mononuclear phagocytes.The Journal of Experimental Medicine, 1988
- Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.The Journal of Immunology, 1987
- Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.The Journal of Immunology, 1987
- Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.The Journal of Immunology, 1986
- Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.The Journal of Immunology, 1984
- Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.The Journal of Immunology, 1983